advisorsecurities master

GOSSGossamer Bio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
16164
Ticker
GOSS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2019-02-08
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
GOSS

Detail

Enriched 2026-08-14 20:47

Market cap
$86,819,177.83
Shares outstanding (class)
488,846,722
Shares outstanding (weighted)
488,846,722
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
162
Location
SAN DIEGO, CA
Description

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data